GlaxoSmithKline Pharmaceuticals was the subject of a search operation initiated by the Directorate of Revenue Intelligence (DRI) at its Mumbai registered office. The search commenced on February 27, 2026, and concluded on February 28, 2026. The company affirmed that its business operations continued as usual without any reported impact. Officials provided full cooperation to the investigating authorities, who were acting under the provisions of the Customs Act, 1962.
Regulatory Authority Initiates Search Action
GlaxoSmithKline Pharmaceuticals Limited has disclosed that its registered office in Mumbai was recently subjected to an investigation by a government authority. The specific authority involved is the Directorate of Revenue Intelligence (DRI), which operates under the Department of Revenue, Government of India.
Details of the Investigation
The action undertaken was an initiation of search, executed pursuant to the powers granted under Section 105 of the Customs Act, 1962. The company confirmed that the search proceedings began on February 27th, 2026, and were officially completed on February 28th, 2026.
The company stated that officials fully cooperated with the departmental officials and responded to all raised queries. Importantly, the announcement confirmed that the search completion had no impact on the financial, operational, or other activities of the listed entity, as business operations continue as usual.
Source: BSE
